Convalescent plasma therapy for persistent hepatitis E virus infection

Michael Ankcorn; Jennifer Gallacher; Samreen Ijaz; Yusri Taha; Heli Harvala; Sheila Maclennan; Emma C. Thomson; Chris Davis; Joshua B. Singer; Ana da Silva Filipe; Katherine Smollett; Marc Niebel; Malcolm G. Semple; Richard S. Tedder; Stuart McPherson

doi:10.1016/j.jhep.2019.04.008

Convalescent plasma therapy for persistent hepatitis E virus infection

Michael Ankcorn^*, Jennifer Gallacher, Samreen Ijaz, Yusri Taha, Heli Harvala, Sheila Maclennan, Emma C. Thomson, Chris Davis, Joshua B. Singer, Ana da Silva Filipe, Katherine Smollett, Marc Niebel, Malcolm G. Semple, Richard S. Tedder, Stuart McPherson

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

16 Citations (Scopus)

Original language	English
Pages (from-to)	434-438
Number of pages	5
Journal	Journal of Hepatology
Volume	71
Issue number	2
DOIs	https://doi.org/10.1016/j.jhep.2019.04.008
Publication status	Published - Aug 2019

Bibliographical note

Funding Information:
Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant .

Funding Information:
Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant. The authors would to thank John Poh, Becky Haywood, Keerthana Jegatheesan, Justin Shute and Steve Dicks in the blood borne virus unit (BBVU), PHE Colindale team for diagnostic work and phylogenetics analysis. We are also grateful for and thank David Williams (PHE, London) and Sreenu Vattipally (CVR, Glasgow) for assistance with using programmes for analysis of short read viral sequences (Illumina). We would like to thank the NHSBT HEV Convalescent Plasma Group which was chaired by Dr Heli Harvala and included Dr Sheila MacLennan, Dr Rekha Anand, Alison Sivyer, Belinda Pelle and Susan Mahenny. Further thanks are extended to Kate Tettmar at the National Transfusion Microbiology Reference Laboratory (NTMRL), NHSBT, Colindale for helping co-ordinate transfer of samples from NTMRL to BBVU.

Keywords

Convalescent plasma
Hepatitis E virus
Immunocompromised
Therapeutics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhep.2019.04.008

Cite this

Ankcorn, M., Gallacher, J., Ijaz, S., Taha, Y., Harvala, H., Maclennan, S., Thomson, E. C., Davis, C., Singer, J. B., da Silva Filipe, A., Smollett, K., Niebel, M., Semple, M. G., Tedder, R. S., & McPherson, S. (2019). Convalescent plasma therapy for persistent hepatitis E virus infection. Journal of Hepatology, 71(2), 434-438. https://doi.org/10.1016/j.jhep.2019.04.008

@article{8569283cd3d047d29b123cbf940080b6,

title = "Convalescent plasma therapy for persistent hepatitis E virus infection",

keywords = "Convalescent plasma, Hepatitis E virus, Immunocompromised, Therapeutics",

author = "Michael Ankcorn and Jennifer Gallacher and Samreen Ijaz and Yusri Taha and Heli Harvala and Sheila Maclennan and Thomson, {Emma C.} and Chris Davis and Singer, {Joshua B.} and {da Silva Filipe}, Ana and Katherine Smollett and Marc Niebel and Semple, {Malcolm G.} and Tedder, {Richard S.} and Stuart McPherson",

note = "Funding Information: Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant . Funding Information: Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant. The authors would to thank John Poh, Becky Haywood, Keerthana Jegatheesan, Justin Shute and Steve Dicks in the blood borne virus unit (BBVU), PHE Colindale team for diagnostic work and phylogenetics analysis. We are also grateful for and thank David Williams (PHE, London) and Sreenu Vattipally (CVR, Glasgow) for assistance with using programmes for analysis of short read viral sequences (Illumina). We would like to thank the NHSBT HEV Convalescent Plasma Group which was chaired by Dr Heli Harvala and included Dr Sheila MacLennan, Dr Rekha Anand, Alison Sivyer, Belinda Pelle and Susan Mahenny. Further thanks are extended to Kate Tettmar at the National Transfusion Microbiology Reference Laboratory (NTMRL), NHSBT, Colindale for helping co-ordinate transfer of samples from NTMRL to BBVU.",

year = "2019",

month = aug,

doi = "10.1016/j.jhep.2019.04.008",

language = "English",

volume = "71",

pages = "434--438",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Convalescent plasma therapy for persistent hepatitis E virus infection

AU - Ankcorn, Michael

AU - Gallacher, Jennifer

AU - Ijaz, Samreen

AU - Taha, Yusri

AU - Harvala, Heli

AU - Maclennan, Sheila

AU - Thomson, Emma C.

AU - Davis, Chris

AU - Singer, Joshua B.

AU - da Silva Filipe, Ana

AU - Smollett, Katherine

AU - Niebel, Marc

AU - Semple, Malcolm G.

AU - Tedder, Richard S.

AU - McPherson, Stuart

N1 - Funding Information: Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant . Funding Information: Additional virology including HEV-Ag neutralisation work and Illumina whole genome sequencing was funded by NHS Blood and Transplant. The authors would to thank John Poh, Becky Haywood, Keerthana Jegatheesan, Justin Shute and Steve Dicks in the blood borne virus unit (BBVU), PHE Colindale team for diagnostic work and phylogenetics analysis. We are also grateful for and thank David Williams (PHE, London) and Sreenu Vattipally (CVR, Glasgow) for assistance with using programmes for analysis of short read viral sequences (Illumina). We would like to thank the NHSBT HEV Convalescent Plasma Group which was chaired by Dr Heli Harvala and included Dr Sheila MacLennan, Dr Rekha Anand, Alison Sivyer, Belinda Pelle and Susan Mahenny. Further thanks are extended to Kate Tettmar at the National Transfusion Microbiology Reference Laboratory (NTMRL), NHSBT, Colindale for helping co-ordinate transfer of samples from NTMRL to BBVU.

PY - 2019/8

Y1 - 2019/8

KW - Convalescent plasma

KW - Hepatitis E virus

KW - Immunocompromised

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=85068827696&partnerID=8YFLogxK

U2 - 10.1016/j.jhep.2019.04.008

DO - 10.1016/j.jhep.2019.04.008

M3 - Letter

C2 - 31075322

AN - SCOPUS:85068827696

SN - 0168-8278

VL - 71

SP - 434

EP - 438

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 2

ER -

Convalescent plasma therapy for persistent hepatitis E virus infection

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Cite this